506373 — Citurgia Biochemicals Income Statement
0.000.00%
Basic MaterialsMicro Cap
Annual income statement for Citurgia Biochemicals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
R2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Interim Report | ARS | ARS | ARS | ARS |
Standards: | — | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 5.62 | 6.12 | 4.04 | 4.36 | 4.76 |
Operating Profit | -5.62 | -6.12 | -4.04 | -4.36 | -4.76 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -5.62 | -6.12 | -4.04 | -4.36 | -4.76 |
Provision for Income Taxes | |||||
Net Income After Taxes | -5.62 | -6.12 | -4.04 | -4.36 | -4.76 |
Net Income Before Extraordinary Items | |||||
Net Income | -5.62 | -6.12 | -4.04 | -4.36 | -4.76 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -5.62 | -6.12 | -4.04 | -4.36 | -4.76 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.043 | -0.046 | -0.031 | -0.165 | -0.18 |